Democratizing knowledge representation with BioCypher S Lobentanzer, P Aloy, J Baumbach, B Bohar, VJ Carey, P Charoentong, ... Nature Biotechnology 41 (8), 1056-1059, 2023 | 25 | 2023 |
Cancer driver drug interaction explorer M Hartung, E Anastasi, ZM Mamdouh, C Nogales, HHHW Schmidt, ... Nucleic Acids Research 50 (W1), W138-W144, 2022 | 14 | 2022 |
SPONGEdb: a pan-cancer resource for competing endogenous RNA interactions M Hoffmann, E Pachl, M Hartung, V Stiegler, J Baumbach, MH Schulz, ... NAR cancer 3 (1), zcaa042, 2021 | 12 | 2021 |
Drugst. One—a plug-and-play solution for online systems medicine and network-based drug repurposing A Maier, M Hartung, M Abovsky, K Adamowicz, GD Bader, S Baier, ... Nucleic Acids Research, gkae388, 2024 | 6 | 2024 |
Inference of differential key regulatory networks and mechanistic drug repurposing candidates from scRNA-seq data with SCANet M Oubounyt, L Adlung, F Patroni, NK Wenke, A Maier, M Hartung, ... Bioinformatics 39 (11), btad644, 2023 | 3 | 2023 |
Network medicine-based epistasis detection in complex diseases: ready for quantum computing M Hoffmann, JM Poschenrieder, M Incudini, S Baier, A Fitz, A Maier, ... Medrxiv, 2023 | 1 | 2023 |
A plug-and-play solution to bring network exploration and drug repurposing to biomedical web platforms M Hartung, A Maier, S Sadegh, J Matschinske, M List, OA Zolotareva, ... RExPO22, 2022 | 1 | 2022 |
Network pharmacology and drug repurposing pave the way for precision oncology ZM Mamdouh, C Nogales, C Macchiusi, MH Elbatreek, ... RExPO22, 2022 | | 2022 |
DESMOND 2.0: Identification of differentially expressed biclusters for unsupervised patient stratification O Zolotareva, OV Isaeva, M Hartung, A Maier, F Delgado-Chaves, ... RExPO22, 2022 | | 2022 |